Astellas Pharma Competitors and Similar CompaniesClear all
Astellas Pharma's competitors and similar companies include Shionogi, Nipro, Hetero, Viatris, Pfizer, AbbVie, Bayer and Immunomedics.
 Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Nipro Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. |  Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs. |  Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | ||
Founding Date | Founding Date 1923 | Founding Date 1878 | Founding Date 1954 | Founding Date 1993 | Founding Date 2020 | Founding Date 1849 | Founding Date 2013 | Founding Date 1863 | Founding Date 1982 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations North Chicago, US HQ Alger, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more | Locations Morris Plains, US HQ | ||
Employees | Employees 14,754 | Employees 4,959 | Employees 38,117 | Employees 6,4132% increase | Employees 38,0003% increase | Employees 88,0006% increase | Employees 50,000 | Employees 94,2454% decrease | Employees 1051% increase |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 12.3 b | Valuation ($) 1.5 b | Valuation ($) N/A | Valuation ($) 14 b | Valuation ($) 163.9 b | Valuation ($) 335 b | Valuation ($) 27.1 b | Valuation ($) N/A |
Financial | |||||||||
Revenue (est.) | Revenue (est.) ¥1.6t (FY, 2024) | Revenue (est.) ¥410.1b (FY, 2024) | Revenue (est.) ¥586.8b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $14.7b (FY, 2024) | Revenue (est.) $63.6b (FY, 2024) | Revenue (est.) $56.3b (FY, 2024) | Revenue (est.) €47.6b (FY, 2023) | Revenue (est.) $295k (FY, 2019) |
Cost of goods | Cost of goods ¥134.6b (FY, 2024) | Cost of goods ¥39.3b (FY, 2024) | Cost of goods ¥356.6b (FY, 2024) | Cost of goods N/A | Cost of goods $9.1b (FY, 2024) | Cost of goods $17.9b (FY, 2024) | Cost of goods $16.9b (FY, 2024) | Cost of goods €7b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit ¥395.8b (FY, 2024) | Gross profit ¥230.2b (FY, 2024) | Gross profit N/A | Gross profit $5.6b (FY, 2024) | Gross profit $45.8b (FY, 2024) | Gross profit $39.4b (FY, 2024) | Gross profit €42.1b (FY, 2023) | Gross profit $295k (FY, 2019) |
Net income | Net income ¥17b (FY, 2024) | Net income ¥160.6b (FY, 2024) | Net income ¥12.2b (FY, 2024) | Net income N/A | Net income ($634.2m) (FY, 2024) | Net income $8.1b (FY, 2024) | Net income $4.3b (FY, 2024) | Net income (€2.9b) (FY, 2023) | Net income ($357.3m) (FY, 2019) |
Operating ⚠ | |||||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 126 (Jan, 2021) | Countries 165 (Q1, 2023) | Countries 125 (FY, 2021) | Countries 70 (FY, 2022) | Countries 83 (FY, 2021) | Countries N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities 4 (FY, 2018) | Manufacturing Facilities N/A | Manufacturing Facilities 36 (Jan, 2021) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 19 (FY, 2022) | Manufacturing Facilities N/A | Manufacturing Facilities N/A |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 40 (Q1, 2023) | Manufacturing Sites 39 (FY, 2021) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A |
Patent Applications (US) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 23 (Jan, 2021) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 230 (Sep, 2022) |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 38 (Jan, 2021) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 405 (Sep, 2022) |
Product Categories | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories 3 (Q1, 2023) | Product Categories N/A | Product Categories 6 (FY, 2022) | Product Categories N/A | Product Categories N/A |
Products | Products N/A | Products N/A | Products N/A | Products 200 (Jan, 2021) | Products 4 (FY, 2022) | Products N/A | Products N/A | Products N/A | Products N/A |
Funding | |||||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 4.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Shionogi
HQ
Osaka, JP
Employees
4,959
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companyNipro
HQ
Settsu, JP
Employees
38,117
Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business.
View companyHetero
HQ
Hyderabad, IN
Employees
6,413↑ 2% increase
Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.
View companyViatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View company